SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunityBio converts from Immunomedics
An SI Board Since February 2023
Posts SubjectMarks Bans Symbol
1544 51 0 IBRX
Emcee:  TinfoilHat Type:  Moderated
Introduction Market Data Compact
Investor in IBRX who previously benefited from crowd-sourced knowledge from the moderated Immunomedics forum
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1544Fitz, as you know, I’ve pounded the table about PSS’s actions. Next steps from galt-37 minutes ago
1543Close to two billion dollars in market cap erased this week by the FDA's ceaFitzhughlaw23 hours ago
1542LOL... :)Davidoff-8 hours ago
1541I am shocked, Shocked, SHOCKED at this.....Fitzhughlaw49 AM
1540Here you go Fitz: businesswire.comerippetoe-8 AM
1539Mine came today too!erippetoe-yesterday
1538A quick follow up on this: Received the book from Amazon this week :)luckydog881yesterday
1537My pleasuremannamal-yesterday
1536Mannamal, good work and analysis. Thank you.Fitzhughlaw1yesterday
1535ImmunityBio Confirms Statistical Power in Pivotal Randomized BCG-Naïve NMIBerippetoe6yesterday
1534So now there are two more new trials listed: clinicaltrials.gov clinicaltrialsmannamal5Wednesday
1533Good. I used this snafu/cluster to add roughly 20k shares.erippetoe4Wednesday
1532BTIG maintained its Buy rating and $13.00 price target on Immunitybio Inc (NASDluckydog882Wednesday
1531Thanks for this. I had an itch to go look to see about counsel. Perhaps someonerippetoe-Tuesday
1530Damages calculations are interesting. On Friday January the 16th, IBRX closed atFitzhughlaw2Tuesday
1529Tales from the Crypt: Was it when Emab was known as "Lymphcide" that DFitzhughlaw3Tuesday
1528I also suspect we'll hear from Adam F. soon too ;)erippetoe3Tuesday
1527All of this highlights how hopelessly naive PSS is about how to manage the reguljargonweary3Tuesday
1526The over/under on when the first class action lawsuit gets filed is three weeks,Fitzhughlaw6Tuesday
1525I didn't get that lucky but bought more shares all the way down to and into erippetoe-Tuesday
1524Probably the institutions needing to cover. My wife just pointed this blurb outerippetoe2Tuesday
1523Exactly. I and others of us here have had cFitzhughlaw6Tuesday
1522I sold some puts as well, so we will see how this all shakes out.luckydog882Tuesday
1521"Clearly they have no friends within the FDA at this point ......" Yeerippetoe-Tuesday
1520FDA Issues Warning To ImmunityBio Over Misleading Anktiva Promotions, Says Falseluckydog884Tuesday
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News